Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes

  • Alireza Esteghamati, Mehrnaz Ghasemiesfe, Mostafa Mousavizadeh, Sina Noshad, Manouchehr Nakhjavani
  • Journal of Diabetes Investigation, October 2013, Wiley
  • DOI: 10.1111/jdi.12157

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/jdi.12157

The following have contributed to this page: ali mousavizadeh

In partnership with:

Contributors